China NMPA Drug Inspection - Anshun Changshouxin New Traditional Chinese Medicine Development Co., Ltd. - Atractylodes lancea
China NMPA drug inspection for Anshun Changshouxin New Traditional Chinese Medicine Development Co., Ltd. published January 22, 2018. Drug: Atractylodes lancea. The Hunan Provincial Food and Drug Administration published its 2018 First Issue Drug Quality Bulletin, detailing result
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Anshun Changshouxin New Traditional Chinese Medicine Development Co., Ltd. published January 22, 2018. Drug: Atractylodes lancea. The Hunan Provincial Food and Drug Administration published its 2018 First Issue Drug Quality Bulletin, detailing result
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox